However, AD brains exhibit depletion of cytosolic Parkin throughout the disease’s progression, which is consistent with a recent study’s findings that Parkin is diminished in the fibroblasts and brain biopsies of AD patients, leading to PINK1 accumulation (Martín-Maestro et al., 2015). This evidence concerns the gene PRKN and Alzheimer disease.